1) Korenkov, M. et al. Evaluation of a rapid antigen test to detect SARS-CoV-2 infection and identify potentially infectious individuals. J Clin Microbiol, Jcm0089621, doi:10.1128/jcm.00896-21 (2021).
2) Stessel, B. et al. Evaluation of a comprehensive pre-procedural screening protocol for COVID-19 in times of a high SARS CoV-2 prevalence: a prospective cross-sectional study. Ann Med 53, 337-344, doi:10.1080/07853890.2021.1878272 (2021).
3) Sharma, A., Ahmad Farouk, I. & Lal, S. K. COVID-19: A Review on the Novel Coronavirus Disease Evolution, Transmission, Detection, Control and Prevention. Viruses 13, doi:10.3390/v13020202 (2021).
4) Lee, J. et al. Clinical Performance of the Standard Q COVID-19 Rapid Antigen Test and Simulation of its Real-World Application in Korea. Ann Lab Med 41, 588-592, doi:10.3343/alm.2021.41.6.588 (2021).
5) Chandel, V. et al. Structure-based drug repurposing for targeting Nsp9 replicase and spike proteins of severe acute respiratory syndrome coronavirus 2. J Biomol Struct Dyn, 1-14, doi:10.1080/07391102.2020.1811773 (2020).
6) Guo, L. et al. Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19). Clin Infect Dis 71, 778-785, doi:10.1093/cid/ciaa310 (2020).
7) Grandjean, L. et al. Long-Term Persistence of Spike Antibody and Predictive Modeling of Antibody Dynamics Following Infection with SARS-CoV-2. Clin Infect Dis, doi:10.1093/cid/ciab607 (2021).
8) Pellini, R. et al. Initial observations on age, gender, BMI and hypertension in antibody responses to SARS-CoV-2 BNT162b2 vaccine. EClinicalMedicine 36, 100928, doi:10.1016/j.eclinm.2021.100928 (2021).
9) de Almeida, S. M. et al. Rapid Serological Tests for Sars-Cov-2: Diagnostic Performance of Four Commercial Assays. Med Princ Pract, doi:10.1159/000516776 (2021).
10) Sun, B. et al. Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients. Emerg Microbes Infect 9, 940-948, doi:10.1080/22221751.2020.1762515 (2020).
11) Jacobs, J. et al. Implementing COVID-19 (SARS-CoV-2) Rapid Diagnostic Tests in Sub-Saharan Africa: A Review. Front Med (Lausanne) 7, 557797, doi:10.3389/fmed.2020.557797 (2020).
12) Ebinger, J. E. et al. Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2. Nat Med 27, 981-984, doi:10.1038/s41591-021-01325-6 (2021).
13) Yang, H., Zhou, B., Prinz, M. & Siegel, D. Proteomic analysis of menstrual blood. Mol Cell Proteomics 11, 1024-1035, doi:10.1074/mcp.M112.018390 (2012).
14) Yovich, J. L., Rowlands, P. K., Lingham, S., Sillender, M. & Srinivasan, S. Pathogenesis of endometriosis: Look no further than John Sampson. Reprod Biomed Online 40, 7-11, doi:10.1016/j.rbmo.2019.10.007 (2020).
15) Alary, M. et al. Evaluation of a modified sanitary napkin as a sample self-collection device for the detection of genital chlamydial infection in women. J Clin Microbiol 39, 2508-2512, doi:10.1128/jcm.39.7.2508-2512.2001 (2001).
16) Wong, S. C. C., Au, T. C. C., Chan, S. C. S., Ng, L. P. W. & Tsang, H. F. Menstrual Blood Human Papillomavirus DNA and TAP1 Gene Polymorphisms as Potential Biomarkers for Screening and Monitoring of Cervical Squamous Intraepithelial Lesion. J Infect Dis 218, 1739-1745, doi:10.1093/infdis/jiy369 (2018).
17) Zhou, J. P. et al. Reproductive hormones in menstrual blood. J Clin Endocrinol Metab 69, 338-342, doi:10.1210/jcem-69-2-338 (1989).
18) Magnay, J. L., Nevatte, T. M., O'Brien, S., Gerlinger, C. & Seitz, C. Validation of a new menstrual pictogram (superabsorbent polymer-c version) for use with ultraslim towels that contain superabsorbent polymers. Fertil Steril 101, 515-522, doi:10.1016/j.fertnstert.2013.10.051 (2014).
19) Warren, L. A. et al. Analysis of menstrual effluent: diagnostic potential for endometriosis. Mol Med 24, 1, doi:10.1186/s10020-018-0009-6 (2018).
20) Ketas, T. J. et al. Antibody Responses to SARS-CoV-2 mRNA Vaccines Are Detectable in Saliva. Pathog Immun 6, 116-134, doi:10.20411/pai.v6i1.441 (2021).
21) Yang, Z. et al. A Convalescent of COVID-19 with RT-PCR Test Continues Positive in Stool. Clin Lab 66, doi:10.7754/Clin.Lab.2020.200623 (2020).
22) Abe, T. et al. A patient infected with SARS-CoV-2 over 100 days. Qjm 114, 47-49, doi:10.1093/qjmed/hcaa296 (2021).
23) Brakenhoff, T. B. et al. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial. Trials 22, 412, doi:10.1186/s13063-021-05241-5 (2021).
24) Chiang, S. H. et al. Development and validation of a quantitative, non-invasive, highly sensitive and specific, electrochemical assay for anti-SARS-CoV-2 IgG antibodies in saliva. PLoS One 16, e0251342, doi:10.1371/journal.pone.0251342 (2021).
25) Tong, X. et al. Analysis of uterine CD49a(+) NK cell subsets in menstrual blood reflects endometrial status and association with recurrent spontaneous abortion. Cell Mol Immunol 18, 1838-1840, doi:10.1038/s41423-021-00687-8 (2021).
26) Ahmed, S. F., Quadeer, A. A. & McKay, M. R. Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies. Viruses 12, doi:10.3390/v12030254 (2020).
27) Nguyen, P. Q. et al. Wearable materials with embedded synthetic biology sensors for biomolecule detection. Nat Biotechnol, doi:10.1038/s41587-021-00950-3 (2021).